Business Description
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd
ISIN : CNE100002CP5
Share Class Description:
SZSE:300534: Class ACompare
Compare
Traded in other countries / regions
300534.China IPO Date
2016-09-13Description
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is mainly engaged in the pharmaceutical business. It is engaged in the research and development of new drugs, traditional Chinese medicine processing and production. Its products portfolio includes Yuan Hu Zhitong Dripping Pills, Qiwei Wenyang Capsule and Xiaoshuan Tongluo Tablets. Its products are used to adjust gas, promote blood circulation, relieve pain, relieve cough, eliminate phlegm, relieve asthma, clear heat, and dispel dampness, among others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.91 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | 1.12 | |||||
| Interest Coverage | 26.2 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.96 | |||||
| Beneish M-Score | -3.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 62.2 | |||||
| 3-Year EBITDA Growth Rate | 73.2 | |||||
| 3-Year Book Growth Rate | -4.6 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.16 | |||||
| 9-Day RSI | 50.95 | |||||
| 14-Day RSI | 51.69 | |||||
| 6-1 Month Momentum % | 26.52 | |||||
| 12-1 Month Momentum % | -11.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.29 | |||||
| Quick Ratio | 1.08 | |||||
| Cash Ratio | 0.61 | |||||
| Days Inventory | 111.21 | |||||
| Days Sales Outstanding | 73.42 | |||||
| Days Payable | 349.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.43 | |||||
| Dividend Payout Ratio | 0.3 | |||||
| Forward Dividend Yield % | 0.43 | |||||
| 5-Year Yield-on-Cost % | 0.42 | |||||
| Shareholder Yield % | 1.17 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.49 | |||||
| Operating Margin % | 8.44 | |||||
| Net Margin % | 3.69 | |||||
| FCF Margin % | 12.95 | |||||
| ROE % | 6.18 | |||||
| ROA % | 2.9 | |||||
| ROIC % | 8.93 | |||||
| ROC (Joel Greenblatt) % | 22.24 | |||||
| ROCE % | 11.3 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 72.67 | |||||
| PE Ratio without NRI | 71.58 | |||||
| Shiller PE Ratio | 86.55 | |||||
| PEG Ratio | 2.37 | |||||
| PS Ratio | 2.71 | |||||
| PB Ratio | 4.47 | |||||
| Price-to-Tangible-Book | 5.04 | |||||
| Price-to-Free-Cash-Flow | 20.76 | |||||
| Price-to-Operating-Cash-Flow | 12.96 | |||||
| EV-to-EBIT | 27.32 | |||||
| EV-to-EBITDA | 27.32 | |||||
| EV-to-Revenue | 2.46 | |||||
| EV-to-FCF | 18.57 | |||||
| Price-to-Projected-FCF | 1.87 | |||||
| Price-to-Graham-Number | 4 | |||||
| Earnings Yield (Greenblatt) % | 3.66 | |||||
| FCF Yield % | 4.82 | |||||
| Forward Rate of Return (Yacktman) % | -40.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,073.956 | ||
| EPS (TTM) (Â¥) | 0.131 | ||
| Beta | 2.29 | ||
| Volatility % | 39.35 | ||
| 14-Day RSI | 51.69 | ||
| 14-Day ATR (Â¥) | 0.455297 | ||
| 20-Day SMA (Â¥) | 9.7345 | ||
| 12-1 Month Momentum % | -11.73 | ||
| 52-Week Range (Â¥) | 6.3 - 11.9 | ||
| Shares Outstanding (Mil) | 303.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Frequently Asked Questions
What is Gansu Longshenrongfa Pharmaceutical Industry Co Ltd(SZSE:300534)'s stock price today?
The current price of SZSE:300534 is ¥9.52. The 52 week high of SZSE:300534 is ¥11.90 and 52 week low is ¥6.30.
When is next earnings date of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd(SZSE:300534)?
The next earnings date of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd(SZSE:300534) is .
Does Gansu Longshenrongfa Pharmaceutical Industry Co Ltd(SZSE:300534) pay dividends? If so, how much?
The Dividend Yield %  of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd(SZSE:300534) is 0.43% (As of Today), Highest Dividend Payout Ratio of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd(SZSE:300534) was 1.67. The lowest was 0.3. And the median was 0.64. The  Forward Dividend Yield % of Gansu Longshenrongfa Pharmaceutical Industry Co Ltd(SZSE:300534) is 0.43%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers